Cardlytics, Inc. (CDLX) — Annual Report

Key Insights

• Cardlytics, Inc. (CDLX) reported a net loss of $22.3 million in fiscal year 2025, a significant improvement from the $32.5 million net loss in the previous year, indicating progress in the company's profitability.
• The company's revenue grew by 12% year-over-year in fiscal year 2025, reaching $380.2 million, driven by growth in the Cardlytics Platform US segment, which accounts for the majority of the company's business.
• Cardlytics' acquisition of HSPEPI Acquisition LLC in December 2023 for $55.2 million appears to have been a strategic move to expand the company's capabilities and market reach.